News
1 April 2026
The European Parliament has approved a negotiating mandate for the Critical Medicines Act, emphasizing local production requirements and joint procurement to enhance medicine supply security across the EU.
Read more...31 March 2026
The 17th Asia Pharma Expo 2026 began on March 29 in Dhaka, featuring over 400 exhibitors from 20+ countries displaying innovations in pharmaceutical processing, packaging, APIs, cleanroom systems, and laboratory instruments.
Read more...EMA's CHMP recommended five new medicines for approval, including conditional authorisation for Adstiladrin and Imdylltra for unmet needs in bladder cancer and lung cancer.[1]
Read more...30 March 2026
The 2026 Asia Pharma Expo kicked off in Bangladesh, bringing together over 400 exhibitors from more than 20 countries to showcase advancements in pharmaceutical manufacturing, equipment, and contract services.
Read more...30 March 2026
The EMA Management Board adopted the 2025 annual report, highlighting 104 new medicine recommendations, and confirmed governance for implementing new EU pharmaceutical legislation impacting regulatory compliance and operations.
Read more...Zimmer Biomet received three awards at the Healthcare Asia Medtech Awards 2026 in Singapore, recognizing breakthroughs in infection prevention, AI-driven recovery solutions, and surgeon engagement across the Asia Pacific region.[1]
Read more...27 March 2026
The European Commission's Pharmaceutical Committee holds its 103rd meeting today, March 27, 2026, focusing on critical regulatory updates impacting pharmaceutical operations across Europe.
Read more...Pharmaceutical MSMEs in Himachal Pradesh urge government intervention as West Asia conflict drives API prices like paracetamol up 80% and packaging materials into short supply.
Read more...The EMA Management Board confirmed the governance structure for new EU pharmaceutical legislation is largely in place, alongside updates on ePI rollout and clinical trials enhancements.
Read more...25 March 2026
Over 250 pharmaceutical, cosmetic, and medical device manufacturers in Haryana, India, are grappling with severe supply chain disruptions due to West Asia unrest, affecting raw materials from China and packaging from South Korea.
Read more...